GlassScriptPhysician profile
Lyndsay J Silver
NPI 1336193655
$1,781.73
in general payments reported to CMS, 2019-2025
17 companies · $130 in 2025
The $130 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $767 · 2022: $660 · 2023: $106 · 2024: $118 · 2025: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $354.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $354.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $591.38 | 2021 | |
| Medtronic, INC. | $259.32 | 2021-2025 | Abre, Venaseal |
| Janssen Pharmaceuticals, INC | $216.99 | 2021-2022 | |
| Edwards Lifesciences Corporation | $161.39 | 2022 | |
| Abbott Laboratories | $133.10 | 2021-2022 | |
| Astellas Pharma US INC | $79.99 | 2022 | |
| Lilly USA, LLC | $72.50 | 2025 | Zepbound |
| Urgo Medical North America, LLC | $43.19 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2 |
| Novo Nordisk INC | $36.17 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $34.67 | 2023 | Eliquis |
| Daiichi Sankyo INC. | $30.43 | 2023 | Injectafer |
| Cardiovascular Systems INC. | $27.01 | 2021 | |
| Merck Sharp & Dohme LLC | $22.35 | 2023 | Verquvo |
| Elutia, INC. | $22.21 | 2021 | |
| Tactile Systems Technology INC | $18.79 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals, LTD. | $18.69 | 2023 | Arcalyst |
| Biosense Webster, INC. | $13.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lyndsay Silver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.